nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—Nelfinavir—acquired immunodeficiency syndrome	0.171	0.389	CrCtD
Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.139	0.317	CrCtD
Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.129	0.295	CrCtD
Indinavir—Nelfinavir—Saquinavir—acquired immunodeficiency syndrome	0.0641	0.255	CrCrCtD
Indinavir—Lopinavir—Ritonavir—acquired immunodeficiency syndrome	0.0562	0.224	CrCrCtD
Indinavir—Saquinavir—Nelfinavir—acquired immunodeficiency syndrome	0.0486	0.193	CrCrCtD
Indinavir—Lopinavir—Saquinavir—acquired immunodeficiency syndrome	0.0426	0.17	CrCrCtD
Indinavir—Saquinavir—Lopinavir—acquired immunodeficiency syndrome	0.0396	0.158	CrCrCtD
Indinavir—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.00955	0.041	CbGbCtD
Indinavir—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.00723	0.031	CbGbCtD
Indinavir—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.00723	0.031	CbGbCtD
Indinavir—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00714	0.0306	CbGbCtD
Indinavir—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.00674	0.0289	CbGbCtD
Indinavir—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.00646	0.0277	CbGbCtD
Indinavir—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.00646	0.0277	CbGbCtD
Indinavir—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0063	0.027	CbGbCtD
Indinavir—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.00609	0.0261	CbGbCtD
Indinavir—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.00609	0.0261	CbGbCtD
Indinavir—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0057	0.0244	CbGbCtD
Indinavir—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.00537	0.023	CbGbCtD
Indinavir—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.00536	0.023	CbGbCtD
Indinavir—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.00536	0.023	CbGbCtD
Indinavir—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00472	0.0202	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00472	0.0202	CbGbCtD
Indinavir—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.00423	0.0181	CbGbCtD
Indinavir—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.00397	0.017	CbGbCtD
Indinavir—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00395	0.017	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00395	0.017	CbGbCtD
Indinavir—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00391	0.0168	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00358	0.0153	CbGbCtD
Indinavir—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00358	0.0153	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00358	0.0153	CbGbCtD
Indinavir—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00358	0.0153	CbGbCtD
Indinavir—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00354	0.0152	CbGbCtD
Indinavir—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00354	0.0152	CbGbCtD
Indinavir—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00336	0.0144	CbGbCtD
Indinavir—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00316	0.0135	CbGbCtD
Indinavir—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00297	0.0127	CbGbCtD
Indinavir—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00285	0.0122	CbGbCtD
Indinavir—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00285	0.0122	CbGbCtD
Indinavir—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.012	CbGbCtD
Indinavir—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00268	0.0115	CbGbCtD
Indinavir—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00268	0.0115	CbGbCtD
Indinavir—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00262	0.0113	CbGbCtD
Indinavir—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00262	0.0113	CbGbCtD
Indinavir—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.011	CbGbCtD
Indinavir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00255	0.0109	CbGbCtD
Indinavir—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0024	0.0103	CbGbCtD
Indinavir—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0024	0.0103	CbGbCtD
Indinavir—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00239	0.0103	CbGbCtD
Indinavir—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00237	0.0102	CbGbCtD
Indinavir—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00237	0.0102	CbGbCtD
Indinavir—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0023	0.00988	CbGbCtD
Indinavir—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00217	0.00931	CbGbCtD
Indinavir—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00217	0.00931	CbGbCtD
Indinavir—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00216	0.00928	CbGbCtD
Indinavir—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00216	0.00928	CbGbCtD
Indinavir—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.0089	CbGbCtD
Indinavir—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00199	0.00853	CbGbCtD
Indinavir—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00193	0.00828	CbGbCtD
Indinavir—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00182	0.0078	CbGbCtD
Indinavir—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.00772	CbGbCtD
Indinavir—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00772	CbGbCtD
Indinavir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00175	0.00749	CbGbCtD
Indinavir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00749	CbGbCtD
Indinavir—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.0074	CbGbCtD
Indinavir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00718	CbGbCtD
Indinavir—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00706	CbGbCtD
Indinavir—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00706	CbGbCtD
Indinavir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00696	CbGbCtD
Indinavir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00153	0.00655	CbGbCtD
Indinavir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00153	0.00655	CbGbCtD
Indinavir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00138	0.00592	CbGbCtD
Indinavir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00138	0.00592	CbGbCtD
Indinavir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00555	CbGbCtD
Indinavir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00116	0.00496	CbGbCtD
Indinavir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00449	CbGbCtD
Indinavir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00449	CbGbCtD
Indinavir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.001	0.0043	CbGbCtD
Indinavir—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000389	0.0768	CbGeAlD
Indinavir—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000253	0.0501	CbGeAlD
Indinavir—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.0002	0.0394	CbGeAlD
Indinavir—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000196	0.0388	CbGeAlD
Indinavir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00015	0.0296	CbGeAlD
Indinavir—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.00015	0.0295	CbGeAlD
Indinavir—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000147	0.0291	CbGeAlD
Indinavir—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000142	0.0281	CbGeAlD
Indinavir—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000122	0.024	CbGeAlD
Indinavir—SLC22A1—blood—acquired immunodeficiency syndrome	0.00012	0.0238	CbGeAlD
Indinavir—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000113	0.0224	CbGeAlD
Indinavir—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000112	0.0221	CbGeAlD
Indinavir—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000112	0.0221	CbGeAlD
Indinavir—ABCC2—blood—acquired immunodeficiency syndrome	0.000108	0.0213	CbGeAlD
Indinavir—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000106	0.0209	CbGeAlD
Indinavir—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000102	0.0201	CbGeAlD
Indinavir—SLC22A1—nervous system—acquired immunodeficiency syndrome	9.77e-05	0.0193	CbGeAlD
Indinavir—CYP2C19—digestive system—acquired immunodeficiency syndrome	9.74e-05	0.0192	CbGeAlD
Indinavir—ABCC1—blood—acquired immunodeficiency syndrome	9.51e-05	0.0188	CbGeAlD
Indinavir—SLCO1A2—nervous system—acquired immunodeficiency syndrome	9.41e-05	0.0186	CbGeAlD
Indinavir—SLC22A1—central nervous system—acquired immunodeficiency syndrome	9.41e-05	0.0186	CbGeAlD
Indinavir—CYP2C19—blood—acquired immunodeficiency syndrome	9.28e-05	0.0183	CbGeAlD
Indinavir—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	9.06e-05	0.0179	CbGeAlD
Indinavir—ABCC1—vagina—acquired immunodeficiency syndrome	8.82e-05	0.0174	CbGeAlD
Indinavir—CYP2C19—vagina—acquired immunodeficiency syndrome	8.6e-05	0.017	CbGeAlD
Indinavir—ABCC1—lung—acquired immunodeficiency syndrome	8.34e-05	0.0165	CbGeAlD
Indinavir—CYP3A5—digestive system—acquired immunodeficiency syndrome	7.67e-05	0.0152	CbGeAlD
Indinavir—CYP2C9—digestive system—acquired immunodeficiency syndrome	7.55e-05	0.0149	CbGeAlD
Indinavir—SLC22A1—brain—acquired immunodeficiency syndrome	7.47e-05	0.0148	CbGeAlD
Indinavir—CYP3A5—blood—acquired immunodeficiency syndrome	7.31e-05	0.0144	CbGeAlD
Indinavir—CYP2C9—blood—acquired immunodeficiency syndrome	7.2e-05	0.0142	CbGeAlD
Indinavir—SLCO1A2—brain—acquired immunodeficiency syndrome	7.19e-05	0.0142	CbGeAlD
Indinavir—CYP3A5—vagina—acquired immunodeficiency syndrome	6.78e-05	0.0134	CbGeAlD
Indinavir—ABCC2—lymph node—acquired immunodeficiency syndrome	6.48e-05	0.0128	CbGeAlD
Indinavir—CYP3A5—lung—acquired immunodeficiency syndrome	6.41e-05	0.0127	CbGeAlD
Indinavir—ABCC1—brain—acquired immunodeficiency syndrome	5.9e-05	0.0117	CbGeAlD
Indinavir—ABCB1—retina—acquired immunodeficiency syndrome	5.81e-05	0.0115	CbGeAlD
Indinavir—CYP3A4—digestive system—acquired immunodeficiency syndrome	5.76e-05	0.0114	CbGeAlD
Indinavir—ABCC1—lymph node—acquired immunodeficiency syndrome	5.7e-05	0.0113	CbGeAlD
Indinavir—CYP2D6—digestive system—acquired immunodeficiency syndrome	5.67e-05	0.0112	CbGeAlD
Indinavir—CYP3A4—blood—acquired immunodeficiency syndrome	5.49e-05	0.0108	CbGeAlD
Indinavir—CYP2D6—blood—acquired immunodeficiency syndrome	5.4e-05	0.0107	CbGeAlD
Indinavir—CYP3A4—nervous system—acquired immunodeficiency syndrome	4.45e-05	0.0088	CbGeAlD
Indinavir—CYP2D6—nervous system—acquired immunodeficiency syndrome	4.38e-05	0.00866	CbGeAlD
Indinavir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	4.29e-05	0.00847	CbGeAlD
Indinavir—CYP2D6—central nervous system—acquired immunodeficiency syndrome	4.22e-05	0.00834	CbGeAlD
Indinavir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	4.13e-05	0.00815	CbGeAlD
Indinavir—ABCB1—digestive system—acquired immunodeficiency syndrome	4.08e-05	0.00806	CbGeAlD
Indinavir—ABCB1—blood—acquired immunodeficiency syndrome	3.88e-05	0.00767	CbGeAlD
Indinavir—ABCB1—bone marrow—acquired immunodeficiency syndrome	3.76e-05	0.00743	CbGeAlD
Indinavir—ABCB1—spinal cord—acquired immunodeficiency syndrome	3.74e-05	0.00739	CbGeAlD
Indinavir—ABCB1—vagina—acquired immunodeficiency syndrome	3.6e-05	0.00711	CbGeAlD
Indinavir—ABCB1—lung—acquired immunodeficiency syndrome	3.4e-05	0.00673	CbGeAlD
Indinavir—CYP2D6—brain—acquired immunodeficiency syndrome	3.35e-05	0.00662	CbGeAlD
Indinavir—ABCB1—nervous system—acquired immunodeficiency syndrome	3.15e-05	0.00623	CbGeAlD
Indinavir—ABCB1—central nervous system—acquired immunodeficiency syndrome	3.04e-05	0.006	CbGeAlD
Indinavir—ABCB1—brain—acquired immunodeficiency syndrome	2.41e-05	0.00476	CbGeAlD
Indinavir—Palpitations—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Indinavir—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Indinavir—Oedema—Delavirdine—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Indinavir—Anorexia—Efavirenz—acquired immunodeficiency syndrome	2.36e-05	0.000329	CcSEcCtD
Indinavir—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	2.36e-05	0.000329	CcSEcCtD
Indinavir—Rash—Didanosine—acquired immunodeficiency syndrome	2.35e-05	0.000329	CcSEcCtD
Indinavir—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Indinavir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Indinavir—Cough—Ritonavir—acquired immunodeficiency syndrome	2.34e-05	0.000327	CcSEcCtD
Indinavir—Headache—Didanosine—acquired immunodeficiency syndrome	2.34e-05	0.000326	CcSEcCtD
Indinavir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	2.33e-05	0.000326	CcSEcCtD
Indinavir—ABCB1—lymph node—acquired immunodeficiency syndrome	2.33e-05	0.0046	CbGeAlD
Indinavir—Shock—Delavirdine—acquired immunodeficiency syndrome	2.33e-05	0.000325	CcSEcCtD
Indinavir—Malaise—Saquinavir—acquired immunodeficiency syndrome	2.33e-05	0.000325	CcSEcCtD
Indinavir—Asthenia—Stavudine—acquired immunodeficiency syndrome	2.32e-05	0.000325	CcSEcCtD
Indinavir—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	2.32e-05	0.000324	CcSEcCtD
Indinavir—Vertigo—Saquinavir—acquired immunodeficiency syndrome	2.32e-05	0.000324	CcSEcCtD
Indinavir—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	2.32e-05	0.000324	CcSEcCtD
Indinavir—Syncope—Saquinavir—acquired immunodeficiency syndrome	2.31e-05	0.000323	CcSEcCtD
Indinavir—Tremor—Lamivudine—acquired immunodeficiency syndrome	2.31e-05	0.000322	CcSEcCtD
Indinavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	2.3e-05	0.000322	CcSEcCtD
Indinavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Indinavir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Indinavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	2.29e-05	0.000321	CcSEcCtD
Indinavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	2.29e-05	0.00032	CcSEcCtD
Indinavir—Asthenia—Abacavir—acquired immunodeficiency syndrome	2.29e-05	0.00032	CcSEcCtD
Indinavir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	2.29e-05	0.00032	CcSEcCtD
Indinavir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	2.28e-05	0.000319	CcSEcCtD
Indinavir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	2.28e-05	0.000319	CcSEcCtD
Indinavir—Chest pain—Ritonavir—acquired immunodeficiency syndrome	2.28e-05	0.000319	CcSEcCtD
Indinavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	2.28e-05	0.000319	CcSEcCtD
Indinavir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	2.27e-05	0.000318	CcSEcCtD
Indinavir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000318	CcSEcCtD
Indinavir—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	2.27e-05	0.000317	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000317	CcSEcCtD
Indinavir—Pruritus—Abacavir—acquired immunodeficiency syndrome	2.26e-05	0.000315	CcSEcCtD
Indinavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	2.26e-05	0.000315	CcSEcCtD
Indinavir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000315	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	2.25e-05	0.000315	CcSEcCtD
Indinavir—Cough—Saquinavir—acquired immunodeficiency syndrome	2.25e-05	0.000315	CcSEcCtD
Indinavir—Angioedema—Lamivudine—acquired immunodeficiency syndrome	2.25e-05	0.000314	CcSEcCtD
Indinavir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000313	CcSEcCtD
Indinavir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	2.24e-05	0.000312	CcSEcCtD
Indinavir—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.000312	CcSEcCtD
Indinavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	2.22e-05	0.000311	CcSEcCtD
Indinavir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	2.22e-05	0.000311	CcSEcCtD
Indinavir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	2.22e-05	0.000311	CcSEcCtD
Indinavir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	2.22e-05	0.00031	CcSEcCtD
Indinavir—Malaise—Lamivudine—acquired immunodeficiency syndrome	2.22e-05	0.00031	CcSEcCtD
Indinavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	2.22e-05	0.00031	CcSEcCtD
Indinavir—Nausea—Didanosine—acquired immunodeficiency syndrome	2.21e-05	0.00031	CcSEcCtD
Indinavir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	2.21e-05	0.000309	CcSEcCtD
Indinavir—Syncope—Lamivudine—acquired immunodeficiency syndrome	2.21e-05	0.000308	CcSEcCtD
Indinavir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	2.2e-05	0.000308	CcSEcCtD
Indinavir—Somnolence—Efavirenz—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Indinavir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Indinavir—Chest pain—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Indinavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Indinavir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	2.19e-05	0.000306	CcSEcCtD
Indinavir—Oedema—Ritonavir—acquired immunodeficiency syndrome	2.19e-05	0.000306	CcSEcCtD
Indinavir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	2.18e-05	0.000305	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	2.18e-05	0.000305	CcSEcCtD
Indinavir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	2.18e-05	0.000304	CcSEcCtD
Indinavir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.000303	CcSEcCtD
Indinavir—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	2.16e-05	0.000302	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	2.16e-05	0.000301	CcSEcCtD
Indinavir—Shock—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.000301	CcSEcCtD
Indinavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Indinavir—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Indinavir—Cough—Lamivudine—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Indinavir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Indinavir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Indinavir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Indinavir—Dizziness—Stavudine—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Indinavir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Indinavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	2.13e-05	0.000298	CcSEcCtD
Indinavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	2.13e-05	0.000298	CcSEcCtD
Indinavir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	2.13e-05	0.000298	CcSEcCtD
Indinavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	2.12e-05	0.000297	CcSEcCtD
Indinavir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	2.12e-05	0.000297	CcSEcCtD
Indinavir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	2.11e-05	0.000296	CcSEcCtD
Indinavir—Pain—Efavirenz—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Constipation—Efavirenz—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Rash—Nevirapine—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Dizziness—Abacavir—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Indinavir—Oedema—Saquinavir—acquired immunodeficiency syndrome	2.11e-05	0.000294	CcSEcCtD
Indinavir—Somnolence—Delavirdine—acquired immunodeficiency syndrome	2.1e-05	0.000294	CcSEcCtD
Indinavir—Headache—Nevirapine—acquired immunodeficiency syndrome	2.1e-05	0.000294	CcSEcCtD
Indinavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000293	CcSEcCtD
Indinavir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000293	CcSEcCtD
Indinavir—Chest pain—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000293	CcSEcCtD
Indinavir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	2.09e-05	0.000292	CcSEcCtD
Indinavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	2.09e-05	0.000291	CcSEcCtD
Indinavir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	2.08e-05	0.000291	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	2.08e-05	0.000291	CcSEcCtD
Indinavir—Shock—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.000289	CcSEcCtD
Indinavir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000289	CcSEcCtD
Indinavir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	2.06e-05	0.000289	CcSEcCtD
Indinavir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	2.06e-05	0.000289	CcSEcCtD
Indinavir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.06e-05	0.000288	CcSEcCtD
Indinavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.06e-05	0.000288	CcSEcCtD
Indinavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.06e-05	0.000287	CcSEcCtD
Indinavir—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Indinavir—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Indinavir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Indinavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Indinavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Indinavir—Rash—Stavudine—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Indinavir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Indinavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Indinavir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Indinavir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.04e-05	0.000284	CcSEcCtD
Indinavir—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.03e-05	0.000284	CcSEcCtD
Indinavir—Headache—Stavudine—acquired immunodeficiency syndrome	2.03e-05	0.000283	CcSEcCtD
Indinavir—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.03e-05	0.000283	CcSEcCtD
Indinavir—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.02e-05	0.000283	CcSEcCtD
Indinavir—Pain—Delavirdine—acquired immunodeficiency syndrome	2.02e-05	0.000283	CcSEcCtD
Indinavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.02e-05	0.000283	CcSEcCtD
Indinavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.02e-05	0.000282	CcSEcCtD
Indinavir—Rash—Abacavir—acquired immunodeficiency syndrome	2.01e-05	0.000281	CcSEcCtD
Indinavir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.01e-05	0.000281	CcSEcCtD
Indinavir—Oedema—Lamivudine—acquired immunodeficiency syndrome	2.01e-05	0.000281	CcSEcCtD
Indinavir—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	2.01e-05	0.000281	CcSEcCtD
Indinavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.01e-05	0.00028	CcSEcCtD
Indinavir—Headache—Abacavir—acquired immunodeficiency syndrome	2e-05	0.000279	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.000279	CcSEcCtD
Indinavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	1.99e-05	0.000278	CcSEcCtD
Indinavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	1.99e-05	0.000278	CcSEcCtD
Indinavir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000277	CcSEcCtD
Indinavir—Shock—Lamivudine—acquired immunodeficiency syndrome	1.98e-05	0.000276	CcSEcCtD
Indinavir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	1.97e-05	0.000275	CcSEcCtD
Indinavir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	1.97e-05	0.000275	CcSEcCtD
Indinavir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	1.96e-05	0.000275	CcSEcCtD
Indinavir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	1.96e-05	0.000274	CcSEcCtD
Indinavir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	1.95e-05	0.000273	CcSEcCtD
Indinavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	1.95e-05	0.000273	CcSEcCtD
Indinavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	1.95e-05	0.000273	CcSEcCtD
Indinavir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	1.95e-05	0.000273	CcSEcCtD
Indinavir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	1.95e-05	0.000272	CcSEcCtD
Indinavir—Somnolence—Ritonavir—acquired immunodeficiency syndrome	1.94e-05	0.000272	CcSEcCtD
Indinavir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	1.94e-05	0.000271	CcSEcCtD
Indinavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	1.93e-05	0.00027	CcSEcCtD
Indinavir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	1.93e-05	0.00027	CcSEcCtD
Indinavir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	1.93e-05	0.000269	CcSEcCtD
Indinavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	1.93e-05	0.000269	CcSEcCtD
Indinavir—Nausea—Stavudine—acquired immunodeficiency syndrome	1.92e-05	0.000269	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	1.92e-05	0.000268	CcSEcCtD
Indinavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	1.91e-05	0.000268	CcSEcCtD
Indinavir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	1.9e-05	0.000266	CcSEcCtD
Indinavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	1.9e-05	0.000266	CcSEcCtD
Indinavir—Nausea—Abacavir—acquired immunodeficiency syndrome	1.89e-05	0.000265	CcSEcCtD
Indinavir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	1.89e-05	0.000264	CcSEcCtD
Indinavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	1.89e-05	0.000264	CcSEcCtD
Indinavir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.89e-05	0.000264	CcSEcCtD
Indinavir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.88e-05	0.000263	CcSEcCtD
Indinavir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.88e-05	0.000262	CcSEcCtD
Indinavir—Somnolence—Saquinavir—acquired immunodeficiency syndrome	1.87e-05	0.000262	CcSEcCtD
Indinavir—Constipation—Ritonavir—acquired immunodeficiency syndrome	1.87e-05	0.000261	CcSEcCtD
Indinavir—Pain—Ritonavir—acquired immunodeficiency syndrome	1.87e-05	0.000261	CcSEcCtD
Indinavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.87e-05	0.000261	CcSEcCtD
Indinavir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.87e-05	0.000261	CcSEcCtD
Indinavir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.86e-05	0.00026	CcSEcCtD
Indinavir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.85e-05	0.000259	CcSEcCtD
Indinavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	1.83e-05	0.000256	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	1.83e-05	0.000256	CcSEcCtD
Indinavir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	1.82e-05	0.000255	CcSEcCtD
Indinavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Indinavir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Indinavir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Indinavir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	1.8e-05	0.000252	CcSEcCtD
Indinavir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	1.8e-05	0.000252	CcSEcCtD
Indinavir—Constipation—Saquinavir—acquired immunodeficiency syndrome	1.8e-05	0.000252	CcSEcCtD
Indinavir—Pain—Saquinavir—acquired immunodeficiency syndrome	1.8e-05	0.000252	CcSEcCtD
Indinavir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	1.79e-05	0.00025	CcSEcCtD
Indinavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1.79e-05	0.00025	CcSEcCtD
Indinavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1.79e-05	0.00025	CcSEcCtD
Indinavir—Somnolence—Lamivudine—acquired immunodeficiency syndrome	1.79e-05	0.00025	CcSEcCtD
Indinavir—Rash—Zidovudine—acquired immunodeficiency syndrome	1.77e-05	0.000248	CcSEcCtD
Indinavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	1.77e-05	0.000248	CcSEcCtD
Indinavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	1.77e-05	0.000248	CcSEcCtD
Indinavir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	1.77e-05	0.000247	CcSEcCtD
Indinavir—Headache—Zidovudine—acquired immunodeficiency syndrome	1.76e-05	0.000246	CcSEcCtD
Indinavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	1.75e-05	0.000244	CcSEcCtD
Indinavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	1.75e-05	0.000244	CcSEcCtD
Indinavir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	1.74e-05	0.000244	CcSEcCtD
Indinavir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	1.74e-05	0.000243	CcSEcCtD
Indinavir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	1.74e-05	0.000242	CcSEcCtD
Indinavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	1.73e-05	0.000242	CcSEcCtD
Indinavir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	1.73e-05	0.000242	CcSEcCtD
Indinavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	1.73e-05	0.000242	CcSEcCtD
Indinavir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	1.73e-05	0.000242	CcSEcCtD
Indinavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	1.72e-05	0.000241	CcSEcCtD
Indinavir—Pain—Lamivudine—acquired immunodeficiency syndrome	1.72e-05	0.00024	CcSEcCtD
Indinavir—Constipation—Lamivudine—acquired immunodeficiency syndrome	1.72e-05	0.00024	CcSEcCtD
Indinavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	1.7e-05	0.000237	CcSEcCtD
Indinavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	1.69e-05	0.000236	CcSEcCtD
Indinavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	1.67e-05	0.000234	CcSEcCtD
Indinavir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	1.67e-05	0.000234	CcSEcCtD
Indinavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	1.67e-05	0.000234	CcSEcCtD
Indinavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	1.66e-05	0.000233	CcSEcCtD
Indinavir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	1.66e-05	0.000233	CcSEcCtD
Indinavir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	1.66e-05	0.000231	CcSEcCtD
Indinavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	1.64e-05	0.00023	CcSEcCtD
Indinavir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	1.64e-05	0.000228	CcSEcCtD
Indinavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	1.62e-05	0.000226	CcSEcCtD
Indinavir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	1.61e-05	0.000225	CcSEcCtD
Indinavir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.6e-05	0.000223	CcSEcCtD
Indinavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.59e-05	0.000222	CcSEcCtD
Indinavir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.59e-05	0.000222	CcSEcCtD
Indinavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	1.57e-05	0.00022	CcSEcCtD
Indinavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.57e-05	0.000219	CcSEcCtD
Indinavir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.56e-05	0.000219	CcSEcCtD
Indinavir—Rash—Efavirenz—acquired immunodeficiency syndrome	1.56e-05	0.000218	CcSEcCtD
Indinavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	1.56e-05	0.000218	CcSEcCtD
Indinavir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.55e-05	0.000217	CcSEcCtD
Indinavir—Headache—Efavirenz—acquired immunodeficiency syndrome	1.55e-05	0.000216	CcSEcCtD
Indinavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.55e-05	0.000216	CcSEcCtD
Indinavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.51e-05	0.000211	CcSEcCtD
Indinavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.5e-05	0.00021	CcSEcCtD
Indinavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.5e-05	0.000209	CcSEcCtD
Indinavir—Rash—Delavirdine—acquired immunodeficiency syndrome	1.49e-05	0.000208	CcSEcCtD
Indinavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.49e-05	0.000208	CcSEcCtD
Indinavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.49e-05	0.000208	CcSEcCtD
Indinavir—Headache—Delavirdine—acquired immunodeficiency syndrome	1.48e-05	0.000207	CcSEcCtD
Indinavir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.48e-05	0.000207	CcSEcCtD
Indinavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	1.47e-05	0.000205	CcSEcCtD
Indinavir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.45e-05	0.000202	CcSEcCtD
Indinavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.44e-05	0.000201	CcSEcCtD
Indinavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.44e-05	0.000201	CcSEcCtD
Indinavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.42e-05	0.000199	CcSEcCtD
Indinavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	1.41e-05	0.000196	CcSEcCtD
Indinavir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	1.39e-05	0.000195	CcSEcCtD
Indinavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	1.39e-05	0.000194	CcSEcCtD
Indinavir—Rash—Ritonavir—acquired immunodeficiency syndrome	1.38e-05	0.000193	CcSEcCtD
Indinavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.38e-05	0.000193	CcSEcCtD
Indinavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.37e-05	0.000192	CcSEcCtD
Indinavir—Headache—Ritonavir—acquired immunodeficiency syndrome	1.37e-05	0.000192	CcSEcCtD
Indinavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.34e-05	0.000187	CcSEcCtD
Indinavir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.33e-05	0.000186	CcSEcCtD
Indinavir—Rash—Saquinavir—acquired immunodeficiency syndrome	1.33e-05	0.000186	CcSEcCtD
Indinavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.33e-05	0.000185	CcSEcCtD
Indinavir—Headache—Saquinavir—acquired immunodeficiency syndrome	1.32e-05	0.000184	CcSEcCtD
Indinavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.3e-05	0.000182	CcSEcCtD
Indinavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.28e-05	0.000178	CcSEcCtD
Indinavir—Rash—Lamivudine—acquired immunodeficiency syndrome	1.27e-05	0.000177	CcSEcCtD
Indinavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.27e-05	0.000177	CcSEcCtD
Indinavir—Headache—Lamivudine—acquired immunodeficiency syndrome	1.26e-05	0.000176	CcSEcCtD
Indinavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.25e-05	0.000175	CcSEcCtD
Indinavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.19e-05	0.000167	CcSEcCtD
